These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12498372)

  • 61. Volumetric neuroimaging in Usher syndrome: evidence of global involvement.
    Schaefer GB; Bodensteiner JB; Thompson JN; Kimberling WJ; Craft JM
    Am J Med Genet; 1998 Aug; 79(1):1-4. PubMed ID: 9738858
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stable and progressive hearing loss in type 2A Usher's syndrome.
    van Aarem A; Pinckers AJ; Kimberling WJ; Huygen PL; Bleeker-Wagemakers EM; Cremers CW
    Ann Otol Rhinol Laryngol; 1996 Dec; 105(12):962-7. PubMed ID: 8973283
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Progressive sensorineural hearing loss in association with distal renal tubular acidosis.
    Brown MT; Cunningham MJ; Ingelfinger JR; Becker AN
    Arch Otolaryngol Head Neck Surg; 1993 Apr; 119(4):458-60. PubMed ID: 8457310
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Audiometric manifestations of Waardenburg's syndrome.
    Oysu C; Baserer N; Tinaz M
    Ear Nose Throat J; 2000 Sep; 79(9):704-9. PubMed ID: 11011489
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical and molecular genetics of Usher syndrome.
    Kimberling WJ; Möller C
    J Am Acad Audiol; 1995 Jan; 6(1):63-72. PubMed ID: 7696679
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Usher's syndrome type 3 in Finland.
    Pakarinen L; Karjalainen S; Simola KO; Laippala P; Kaitalo H
    Laryngoscope; 1995 Jun; 105(6):613-7. PubMed ID: 7769945
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Otoacoustic emission measurements: clinical case reports. Part III].
    Kowalska S; Sułkowski W
    Otolaryngol Pol; 1997; 51(4):396-401. PubMed ID: 9489385
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Linkage studies of Usher syndrome: analysis of an Acadian kindred in Louisiana.
    Pelias MZ; Lemoine DR; Kossar AL; Ward LJ; Wilson AF; Elston RC
    Cytogenet Cell Genet; 1988; 47(1-2):111-2. PubMed ID: 3162715
    [No Abstract]   [Full Text] [Related]  

  • 69. Apparent Usher Syndrome Caused by the Combination of BBS1-Associated Retinitis Pigmentosa and SLC26A4-Associated Deafness.
    DeLuca AP; Weed MC; Haas CM; Halder JA; Stone EM
    JAMA Ophthalmol; 2015 Aug; 133(8):967-8. PubMed ID: 26022370
    [No Abstract]   [Full Text] [Related]  

  • 70. Genetic mapping of the gene for Usher syndrome: linkage analysis in a large Samaritan kindred.
    Bonné-Tamir B; Korostishevsky M; Kalinsky H; Seroussi E; Beker R; Weiss S; Godel V
    Genomics; 1994 Mar; 20(1):36-42. PubMed ID: 8020954
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hearing loss in chronic alcoholics.
    Niedzielska G; Katska E; Kusa W
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():99-101. PubMed ID: 11977373
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Twelve novel myosin VIIA mutations in 34 patients with Usher syndrome type I: confirmation of genetic heterogeneity.
    Janecke AR; Meins M; Sadeghi M; Grundmann K; Apfelstedt-Sylla E; Zrenner E; Rosenberg T; Gal A
    Hum Mutat; 1999; 13(2):133-40. PubMed ID: 10094549
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Audiological and radiological characteristics of a family with T961G mitochondrial mutation.
    Turchetta R; Mazzei F; Celani T; Cammeresi MG; Orlando MP; Altissimi G; de Vincentiis C; D'Ambrosio F; Messineo D; Ferraris A; Cianfrone G
    Int J Audiol; 2012 Dec; 51(12):870-9. PubMed ID: 23013294
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Problem and assignment for distinguishing the Usher syndrome type].
    Iwasaki S; Yoshimura H; Takeichi N; Satou H; Ishikawa K; Kaga K; Kumakawa K; Nagai K; Furuya N; Ikezono T; Nakanishi H; Naitou Y; Fukushima K; Tono T; Kimitsuki T; Nishio S; Takumi Y; Usami S
    Nihon Jibiinkoka Gakkai Kaiho; 2012 Oct; 115(10):894-901. PubMed ID: 23214047
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical presentation of DFNB12 and Usher syndrome type 1D.
    Bork JM; Morell RJ; Khan S; Riazuddin S; Wilcox ER; Friedman TB; Griffith AJ
    Adv Otorhinolaryngol; 2002; 61():145-52. PubMed ID: 12408077
    [No Abstract]   [Full Text] [Related]  

  • 76. The ophthalmological course of Usher syndrome type III.
    Pakarinen L; Tuppurainen K; Laippala P; Mäntyjärvi M; Puhakka H
    Int Ophthalmol; 1995-1996; 19(5):307-11. PubMed ID: 8864816
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A genetic analysis of retinitis pigmentosa.
    Boughman JA; Fishman GA
    Br J Ophthalmol; 1983 Jul; 67(7):449-54. PubMed ID: 6860611
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Localization of Usher syndrome type II to chromosome 1q.
    Kimberling WJ; Weston MD; Möller C; Davenport SL; Shugart YY; Priluck IA; Martini A; Milani M; Smith RJ
    Genomics; 1990 Jun; 7(2):245-9. PubMed ID: 2347588
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The prevalence of Usher syndrome and other retinal dystrophy-hearing impairment associations.
    Rosenberg T; Haim M; Hauch AM; Parving A
    Clin Genet; 1997 May; 51(5):314-21. PubMed ID: 9212179
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hearing impairment in Usher's syndrome.
    Pennings RJ; Wagenaar M; van Aarem A; Huygen PL; Kimberling WJ; Cremers CW
    Adv Otorhinolaryngol; 2002; 61():184-91. PubMed ID: 12408083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.